WORCESTER, Mass., Jan. 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has thus far received an aggregate of over $800,000 in initial purchase orders for the Company’s proprietary Crave-NX(TM) 7-Day Diet Aid Spray (www.Crave-NX.com). These initial orders come as part of the Company’s agreement announced earlier this week with a major nationwide pharmacy chain to market the Company’s Crave-NX(TM) 7-Day Diet Aid Spray throughout the pharmacy’s nationwide network of over 7,000 stores.
